ON-LINE REGISTRATION IS NOW OPEN.
Afternoon 1:30 P.M. - 3:30 P.M.
Recent Advances in Medicine
Zoonosis and Human Health
Dr. J. Scott Weese
Dr. J. Scott Weese is a specialist in infectious diseases. A prominent researcher and clinical teacher, he is recognized world-wide for his pioneering work in preventing and managing outbreaks of antibiotic resistant infections passed from horses to humans. His work transcends veterinary medicine, and clearly impacts on understanding and guarding human health. His presentation will address ‘ZOONOSIS (TRANSMISSION OF PATHOLOGIES FROM ANIMALS TO HUMANS) AND IMPLICATIONS FOR HUMAN HEALTH’ .
Dr. Christopher Schlachta
Dr. Christopher M. Schalachta is a pioneering contributor to the development and implementation of computer-assisted and minimally invasive gastro-intestinal surgeries. His groundbreaking works at the University of Western Ontario’s Medical School and Hospitals earned him a Queen Elizabeth II Diamond Jubilee Medal. Highly respected in his professional community, he is a past president of The Canadian Association of General Surgeons, and past Governor of The American College of Surgeons. His presentation will address ‘Advancements in Computer-Assisted Surgical Procedures’.
The Aging Brain
Dr. Allison Sekuler
Dr. Allison Sekuler's numerous awards for research, teaching and leadership include recognition for her achievements in the fields of aging and vision science, cognitive neuroscience, learning and neuroplasticity, neuroimaging, and neurotechnology. After distinguished professional contributions at the University of Toronto, her career developed further in her decade of work as professor of neuroscience and behaviour at McMaster University, during which she was the first Canada Research Chair in Cognitive Neuroscience.
In 2017, Baycrest Health Sciences appointed her as Vice President, Research, and the Sandra A. Rotman Chair in Cognitive Neuroscience. She also serves as Managing Director for the Rotman Research Institute and the Centre for Aging and Brain Health Innovation. Dr. Sekuler Chairs the Natural Sciences and Engineering Research Council of Canada's Scholarship and Fellowship Group, serves on NSERC’s Committee for Discovery Research, and is Scientific Officer for the NSERC-CIHR Collaborative Health Research Program
Stem Cell Research in Animals and Humans
Dr. Thomas Koch
Dr. Koch is an Associate Professor in the Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Canada, and an Associate Professor in the Department of Clinical Studies, Orthopaedic Research Lab, Aarhus University, Denmark. He received his Veterinary degree from the Royal Veterinary and Agricultural University, Copenhagen, Denmark. He worked in mixed animal and equine private veterinary practices before completing an Internship in large animal medicine and surgery at the Ontario Veterinary College. He went on to complete a Residency of Internal Medicine at the Ontario Veterinary College, where he continues to work as part of the emergency service at the Teaching Hospital.
Dr. Koch’s current research focus is on stem cell and tissue engineering-based therapies with joint cartilage repair being the main area of investigation. Studies on equine, canine and human stem cells, joint cartilage and synovial joint health are pursued in parallel.
ARE BACTERIOPHAGES THE MAGIC BULLET FOR THE 21ST CENTURY?
Dr. Andrew KropinskiI
Infections caused by antibiotic-resistant germs are difficult, and sometimes impossible, to treat. In the past the pharmaceutical companies could be relied on to produce new antibiotics,. We must seriously consider alternatives, one of which are viruses (bacteriophages, phages) which specifically kill bacteria. These are used extensively in (Republic of) Georgia, and Dr. Kropinski will discuss whether there is a place for them in North American medicine.
Andrew Kropinski is a “retired” academic (Queen’s University, Kingston) and government (Public Health Agency of Canada) research scientist, who keeps active by helping faculty and their students at the University of Guelph with genomic problems. He also is actively involved in the classification of bacteriophages, and offers workshops on phage genome characterization. His hobbies include travel and cooking.
Pharmacogenomics, a Prime Example of Individualized Medicine for You
Dr. Iris Cohn
Iris joined The Hospital for Sick Children in October 2013 as a Clinical Research Pharmacogenetics Advisor in the Division of Clinical Pharmacology & Toxicology, she has built the Pharmacogenetics (Pgx ) pogram at SickKids and conducts this clinic under the supervision of Dr. Ito. Iris' research focuses on optimizing a design for a future pharmacogenetics service which includes different technology platforms, to advance pharmacogenetics testing into the therapeutic management of daily clinical care. She is a graduate from pharmacy school of the Heinrich-Heine-University in Germany(1995) and a registered pharmacist in Germany, USA and Canada. She served as clinical pharmacist from (1996-2012) in several hospital settings.
Advances in the Treatments of Cancer
Dr. Meredith Giuliani
Dr. Meredith Giuliani qualified in medicine at St. George’s University, London, England, and later, was awarded an M.Ed. degree by the University of Toronto. A Fellow of the Royal College of Physicians, in 2016 she was given special recognition in Radiation Oncology by the Canadian Medical Association , when it named her “A Noteworthy Young Leader In Medicine”. Her presentation will address ‘Advances in the Treatments of Cancer’.
Guelph General Hospital's Strategies For Adapting To 21st Century Advances In Medicine
The hospital's President & CEO, its Chief of Medical Staff, and selected medical specialists, will present our concluding seminar. Their intention will be to inform our members of how the GGH's planners and clinicians are preparing to meet the needs, expectations and demands of 21st century informed consumers. Additional inputs might come from our local MPP, Mike Schreiner.